Women Health Therapeutics Market Size, Share, Trends, Growth 2032

Women Health Therapeutics Market Insights

Zion Market Research has published a report on the global Women Health Therapeutics Market, estimating its value at USD 76.28 Billion in 2023, with projections indicating that it will reach USD 130.55 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 5.5% over the forecast period 2024-2032. The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Women Health Therapeutics Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

Global Women Health Therapeutics Market OVerview

Women health therapeutics has been gaining significance since last three decades. In 1991, NHLBI (National Heart, Lung, and Blood Institute) of the U.S. NIH (National Institutes of Health) sponsored the Women’s Health Initiative (WHI). As per this initiative, it focusses on various strategies including prevention of heart disorders, colorectal cancer, osteoporosis, and breast cancer in postmenopausal women over the long term. The key WHI study were divided into three parts, namely, clinical study, observational research, and community prevention study. The data collection for the WHI study was completed in 2005 by NIH. Furthermore, WHI contributes majorly towards women’s health & therapeutics through ancillary studies. All these aforementioned factors are anticipated to spearhead the growth of women health therapeutics industry.

Women Health Therapeutics Market Growth Drivers

Favorable initiatives carried out by NIH that include WHISH (Women’s Health Initiative Strong and Healthy Study), WHISPER (Women’s Health Initiative Sleep Hypoxia Effects on Resilience), and OPACH (Objective Physical Activity and Cardiovascular Health Study) will shape the market growth dimensions over the forecast period. Apart from this, constant surge in occurrence of chronic & lifestyle related diseases in women will embellish women health therapeutics market trends. Furthermore, rise in the funding of healthcare research events along with growing research in the field of oncology & breast cancer will form a strong foundation for women health therapeutics market. With rise in complications pertaining to pregnancy and launching of novel therapeutic drugs for treating the pregnancy related problems, women health therapeutics industry is slated to witness extensive surge within the next couple of years.

Request Free Sample

Moreover, increment in awareness associated with cancer, infections, menopause, and osteoporosis will proliferate the market size. New drug treatments introduced by giant players of pharma industry will chart a profitable roadmap for women health therapeutics market in the upcoming years. Rise in the infertility rates in women coupled with surge in the gynecological disorders will proliferate the industry size during the years ahead. Favorable government schemes supported by strong healthcare amenities in developed countries as well as emerging nations will kindle the emergence of the market over 2020-2026.

Women Health Therapeutics Market: Report Scope

North America To Retain Regional Market Dominance Over 2024-2032

The business growth in North America over 2024-2032 can be attributed to large-scale approval of generic medicines by U.S. FDA and occurrence of chronic disorders in women population base. Apart from this, rise in geriatric female population prone to chronic disorders and introduction of new drug therapies to treat such severe ailments will augment market value and add to industry ascension during the assessment period. Moreover, U.S. and Canada are likely to be the key regional growth drivers within the span of next couple of years.

Global Women Health Therapeutics Market: Competitive Players

The major players that dominate the global women health therapeutics market include:

• Novartis International AG
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• Merck & Co., Inc
• Pfizer, Inc
• Bayer AG
• Novo Nordisk A/S

The global Women Health Therapeutics Market is segmented as follows:

 By Type  

• Infection
• Pregnancy
• Oncology

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa